Top

Published in:

Open Access 01-12-2022 | Commentary

Activities supporting the growth of Clinical Trial Networks in Australia

Authors: Fiona Nemeh, Rachelle Buchbinder, Carmel M. Hawley, Mark R. Nelson, Jacqui G. Waterkeyn, Christopher M. Reid

Published in: Trials | Issue 1/2022

Abstract

Clinical Trial Networks in which trialists work collaboratively enable multi-site, large-scale, high-quality clinical trials to be efficiently run. Although the benefits of Clinical Trial Networks are largely known, establishing a Clinical Trial Network can be complex. There are many factors for clinicians and researchers to consider, and there is currently a paucity of information on how to form a Clinical Trial Network. This article provides a suggested roadmap on how to establish a Clinical Trial Network. The Australian Clinical Trials Alliance (ACTA) is the peak body for Clinical Trial Networks, Coordinating Centres and Registries in Australia, and has produced several resources to support the effective and efficient running of clinical trials. This guide has come about through discussions with members of the ACTA Clinical Trial Network Sector Expansion Reference Group consisting of clinical trialists, clinicians, researchers, and consumers.

Sjoquist, KM, Zalcberg, JR. Clinical trials - advancing national cancer care. Cancer Forum. 2013;37(1):80–87. https://search.informit.org/doi/abs/10.3316/INFORMIT.399530725733200.

Bourne AM, Whittle SL, Richards BL, Maher CG, Buchbinder R. The scope, funding and publication of musculoskeletal clinical trials performed in Australia. Med J Australia. 2014;200(2):88–91. https://doi.org/10.5694/mja13.10907.CrossRefPubMed

Olver IN, Keech AC. Forming networks for research: proposal for an Australian clinical trials alliance. Med J Australia. 2013;198(5):254–5. https://doi.org/10.5694/mja12.11067.CrossRefPubMed

Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356(9248):2139–43.CrossRefPubMed

Buchbinder R, Maher C, Harris IA. Setting the research agenda for improving health care in musculoskeletal disorders. Nat Rev Rheumatol. 2015;11(10):597–605. https://doi.org/10.1038/nrrheum.2015.81.CrossRefPubMed

Rigg JR, Jamrozik K, Myles PS, Silbert BS, Peyton PJ, Parsons RW, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359(9314):1276–82. https://doi.org/10.1016/S0140-6736(02)08266-1.CrossRefPubMed

Story D, Myles P. Large multicentre trials in anaesthesia: the ANZCA Clinical Trials Group. London, England: SAGE Publications Sage UK; 2005.

Australian Clinical Trials Alliance (ACTA). Activities critical to success and growth of Clinical Trials Networks: Sector consultation [Internet]. 2019 [cited 2021 Nov 25]. Available from https://clinicaltrialsalliance.org.au/resource/activities-critical-to-success-and-growth-of-clinical-trials-networks-sector-consultation/

Australian Clinical Trials Alliance (ACTA). Establishment of new clinical trial networks [Internet]. 2020 [cited 2020 Aug 17]. Available from: https://clinicaltrialsalliance.org.au/resource/guidance-for-new-clinical-trial-networks/

10.

Buchbinder R, Bourne A, Latimer J, Harris I, Whittle SL, Richards B, et al. Early development of the Australia and New Zealand Musculoskeletal Clinical Trials Network. Intern Med J. 2020;50(1):17–23. https://doi.org/10.1111/imj.14191.CrossRefPubMed

11.

Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, et al. Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med. 2020;382(26):2504–13. https://doi.org/10.1056/NEJMoa1915833.CrossRefPubMed

12.

Myles PS, Leslie K, McNeil J, Forbes A, Chan M, Group B-AT. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004;363(9423):1757–63. https://doi.org/10.1016/S0140-6736(04)16300-9.CrossRefPubMed

13.

Peake SL, Delaney A, Bailey MJ, Bellomo R, Cameron P, Cooper DJ, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506. https://doi.org/10.1056/NEJMoa1404380.CrossRefPubMed

14.

Young P, Saxena M, Bellomo R, Freebairn R, Hammond N, van Haren F, et al. Acetaminophen for fever in critically ill patients with suspected infection. N Engl J Med. 2015;373(23):2215–24. https://doi.org/10.1056/NEJMoa1508375.CrossRefPubMed

15.

Myles PS, Smith J, Knight J, Cooper DJ, Silbert B, McNeil J, et al. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial: rationale and design. American Heart J. 2008;155(2):224–30. https://doi.org/10.1016/j.ahj.2007.10.003.CrossRef

16.

Myles PS, Smith JA, Kasza J, Silbert B, Jayarajah M, Painter T, et al. Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial. J Thorac Cardiovasc Surg. 2019;157(2):633–40. https://doi.org/10.1016/j.jtcvs.2018.08.114.CrossRefPubMed

17.

Myles PS, Smith JA, Kasza J, Silbert B, Jayarajah M, Painter T, et al. Tranexamic acid in coronary artery surgery: one-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial. J Thorac Cardiovasc Surg. 2019;157(2):644–52. e9.CrossRefPubMed

18.

Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y. Bentum-Puijk Wv, et al. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc. 2020;17(7):879–91. https://doi.org/10.1513/AnnalsATS.202003-192SD.CrossRefPubMedPubMedCentral

19.

Denholm JT, Davis J, Paterson D, Roberts J, Morpeth S, Snelling T, et al. The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):1–3. https://doi.org/10.1186/s13063-020-04576-9.CrossRef

20.

Morrish AT, Hawley CM, Johnson DW, Badve SV, Perkovic V, Reidlinger DM, et al. Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network. Kidney Int. 2014;85(1):23–30. https://doi.org/10.1038/ki.2013.391.CrossRefPubMed

21.

Rigatto C, Walsh M, Zalunardo N, Clase CM, Manns BJ, Madore F, et al. Establishing a Canadian national clinical trials network for kidney disease: proceedings of a planning workshop. Can J Kidney Health Dis. 2015;2(1):46. https://doi.org/10.1186/s40697-015-0080-7.CrossRefPubMedPubMedCentral

22.

Australian Clinical Trials Alliance (ACTA). Stakeholder mapping for emerging CTNs [Internet]. 2020 [cited 2020 Aug 17]. Available from:https://clinicaltrialsalliance.org.au/resource/stakeholder-mapping-for-emerging-clinical-trial-networks/

23.

Hagen NA, Stiles CR, Biondo PD, Cummings GG, Fainsinger RL, Moulin DE, et al. Establishing a multicentre clinical research network: lessons learned. Curr Oncol. 2011 Oct;18(5):243–9. https://doi.org/10.3747/co.v18i5.814.CrossRef

24.

Robison L, Cho Y, Viecelli AK, Johnson DW, Hawley CM, Valks A, et al. Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response. Trials. 2021 Dec;22(1):1–9. https://doi.org/10.1186/s13063-021-05200-0.CrossRef

25.

Bruner DW, O'Mara A. Nurse scientists in cancer cooperative groups. Seminars in Oncology Nursing. 2014;30(1):4-10. https://doi.org/10.1016/j.soncn.2013.12.002.

26.

Australian Clinical Trials Alliance (ACTA). Clinical trials network gap analysis. Unpublished report. 2019. Box Diagram 1, Features of CTNs which contribute to an efficient and effective healthcare system; p. 5.

27.

Australian Clinical Trials Alliance (ACTA). Clinical trial network governance structure [Internet]. 2018 [cited 2018 Oct 10]. Available from: https://clinicaltrialsalliance.org.au/wp-content/uploads/2019/12/CTN-governance-structure_v1.0FINAL.pdf

28.

Australian Clinical Trials Alliance (ACTA). Report on the activities and achievements of clinical trial networks in Australia 2004–2014 [Internet]. 2015 [cited 2019 Aug 17]. Available from: http://www.clinicaltrialsalliance.org.au/about-acta/major-initiatives/

29.

Australian Clinical Trials Alliance (ACTA). Economic evaluation of investigator-initiated clinical trials conducted by networks. [Internet]. 2017 [cited 2020 Aug 17]. Available from: https://clinicaltrialsalliance.org.au/resource/economic-evaluation-of-investigator-initiated-clinical-trials-conducted-by-networks/

30.

Darbyshire J, Sitzia J, Cameron D, Ford G, Littlewood S, Kaplan R, et al. Extending the clinical research network approach to all of healthcare. Ann Oncol; 2011. 22. vii36–vii43. Available from: https://doi.org/10.1093/annonc/mdr424

31.

McFadden E, Bashir S, Canham S, Darbyshire J, Davidson P, Day S, et al. The impact of registration of clinical trials units: the UK experience. Clin Trials. 2015;12(2):166–73. https://doi.org/10.1177/1740774514561242.CrossRefPubMed

32.

National Institute for Health Research (NIHR). Annual Statistics [Internet]. 2020 [cited 2020 Aug 17]. Available from: https://www.nihr.ac.uk/about-us/our-contribution-to-research/research-performance/annual-statistics.htm

33.

Simes RJ, Webb SA. Sustaining Australian research through clinical trials and investigator networks. Med J Australia. 2013;198(3):127–8. https://doi.org/10.5694/mja13.10066.CrossRefPubMed

34.

Orygen. News and Events [Internet]. 2020 [cited 2020 Aug 17]. Available from: https://www.orygen.org.au/About/News-And-Events/2020/Wellcome-Trust-delivers-$11-9-million-boost-to-Ory

35.

ASPREE.org. NIH funds follow up observational study ASPREE-XT (eXTension) [Internet]. 2019 [cited 2020 Aug 17]. Available from: https://aspree.org/aus/for-clinicans/about-aspree-xt/

Title: Activities supporting the growth of Clinical Trial Networks in Australia
Authors: Fiona Nemeh
Rachelle Buchbinder
Carmel M. Hawley
Mark R. Nelson
Jacqui G. Waterkeyn
Christopher M. Reid
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-021-05974-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Activities supporting the growth of Clinical Trial Networks in Australia

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Enteral versus parental nutrition after pancreaticoduodenectomy under enhanced recovery after surgery protocol: study protocol for a multicenter, open-label randomized controlled trial (ENE-PAN trial)

E-HEalth treatment in Long-term Dialysis (E-HELD): study protocol for a multicenter randomized controlled trial evaluating personalized Internet-based cognitive-behavioral therapy in dialysis patients

Retention in RCTs of physical rehabilitation for adults with frailty: a systematic review and meta-analysis

Antibiotic prophylaxis for percutaneous renal biopsy: study protocol for a prospective randomized trial

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)

Personalized Disease Prevention (PDP): study protocol for a cluster-randomized clinical trial